ICON announced its intention to acquire Aptiv Solutions
ICON announced its intention to acquire Aptiv Solutions, a Reston, Va.-based services organization with operations in 16 countries. According to a press release, ICON views Aptiv's strengths in the design and execution of adaptive clinical trials through its ADDPLAN software a strength for its clients. Aptiv also owns a full-service, oncology-focused CRO in Japan, which will be combined with ICON's current operations in Tokyo and Osaka.
Read the full release here.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.